Long-term persistence and other treatment patterns among bio-naïve patients with Crohn’s disease treated with ustekinumab or adalimumab
Author:
Affiliation:
1. Analysis Group, Inc, Montréal, QC, Canada
2. Janssen Scientific Affairs, LLC, Horsham, PA, USA
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2246882
Reference33 articles.
1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2. Crohn’s & Colitis Foundation of America (CCFA). The facts about inflammatory bowel diseases. 2014. Available at http://www.crohnscolitisfoundation.org/assets/pdfs/updatedibdfactbook.pdf.
3. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
4. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study
5. Burden of Crohn’s disease in the United States: long-term healthcare and work-loss related costs
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States;Crohn's & Colitis 360;2023-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3